Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States

CA Cancer Journal for Clinicians

Volumn 68, Issue 1, 2018, Pages 31-54

  Islami, Farhad ^a   Goding Sauer, Ann ^a   Miller, Kimberly D ^a   Siegel, Rebecca L ^a   Fedewa, Stacey A ^a   Jacobs, Eric J ^a   McCullough, Marjorie L ^a   Patel, Alpa V ^a   Ma, Jiemin ^a   Soerjomataram, Isabelle ^b   Flanders, W Dana ^c   Brawley, Otis W ^a   Gapstur, Susan M ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c EMORY UNIVERSITY   (United States)

Author keywords

cancer; population attributable fraction; prevention; risk factor

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; CALCIUM INTAKE; CANCER INCIDENCE; CANCER MORTALITY; CAUSAL ATTRIBUTION; CIGARETTE SMOKING; COLORECTAL CANCER; DIETARY FIBER; DISEASE ASSOCIATION; FRUIT; HELICOBACTER INFECTION; HEPATITIS B; HEPATITIS C; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALIGNANT NEOPLASM; NONHUMAN; OBESITY; PAPILLOMAVIRUS INFECTION; PASSIVE SMOKING; PHYSICAL INACTIVITY; PRIORITY JOURNAL; RADIATION EXPOSURE; RED MEAT; RISK FACTOR; ULTRAVIOLET RADIATION; UNITED STATES; VEGETABLE; ADULT; AGED; CANCER REGISTRY; FEMALE; FORECASTING; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; REGISTER; RISK REDUCTION; STATISTICS AND NUMERICAL DATA; SURVIVAL ANALYSIS; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FORECASTING; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; REGISTRIES; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 85034623465     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21440     Document Type: Article

References (142)

1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7-30.
2. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20:2006-2014.
3. Agency for Healthcare Research and Quality (AHRQ). Total Expenses and Percent Distribution for Selected Conditions by Type of Service: United States, 2014. Medical Expenditure Panel Survey Household Component Data (generated interactively 2017). Rockville, MD: AHRQ, US Department of Health and Human Services; 2017.
4. Danaei G, Ding EL, Mozaffarian D, et al. The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors [serial online]. PLoS Med. 2009;6:e1000058.
5. Siegel RL, Jacobs EJ, Newton CC, et al. Deaths due to cigarette smoking for 12 smoking-related cancers in the United States. JAMA Intern Med. 2015;175:1574-1576.
6. Nelson DE, Jarman DW, Rehm J, et al. Alcohol-attributable cancer deaths and years of potential life lost in the United States. Am J Public Health. 2013;103:641-648.
7. Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16:36-46.
8. Makarova-Rusher OV, Altekruse SF, McNeel TS, et al. Population attributable fractions of risk factors for hepatocellular carcinoma in the United States. Cancer. 2016;122:1757-1765.
9. Lortet-Tieulent J, Goding Sauer A, Siegel RL, et al. State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Intern Med. 2016;176:1792-1798.
10. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-e616.
11. World Cancer Research Fund/American Institute for Cancer Research. Preventability Estimates. wcrf.org/int/cancer-facts-figures/preventability-estimates. Accessed August 31, 2017.
12. International Agency for Research on Cancer (IARC). Agents Classified by the IARC Monographs, Volumes 1-119. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC; 2017. monographs.iarc.fr/ENG/Classification/. Accessed August 31, 2017.
13. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009;10:321-322.
14. Secretan B, Straif K, Baan R, et al. A review of human carcinogens—Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10:1033-1034.
15. El Ghissassi F, Baan R, Straif K, et al. A review of human carcinogens—Part D: radiation. Lancet Oncol. 2009;10:751-752.
16. Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015;16:1599-1600.
17. Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794-798.
18. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Findings and Reports. wcrf.org/int/research-we-fund/continuous-update-project-findings-reports. Accessed August 31, 2017.
19. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: American Institute for Cancer Research; 2007.
20. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Food, Nutrition, Physical Activity, and the Prevention of Pancreatic Cancer. wcrf.org/sites/default/files/Pancreatic-Cancer-2012-Report.pdf. Accessed August 31, 2017.
21. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Food, Nutrition, Physical Activity, and the Prevention of Endometrial Cancer. wcrf.org/sites/default/files/Endometrial-Cancer-2013-Report.pdf. Accessed August 31, 2017.
22. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Food, Nutrition, Physical Activity, and the Prevention of Ovarian Cancer. wcrf.org/sites/default/files/Ovarian-Cancer-2014-Report.pdf. Accessed August 31, 2017.
23. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Gallbladder Cancer. wcrf.org/sites/default/files/Gallbladder-Cancer-2015-Report.pdf. Accessed August 31, 2017.
24. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Kidney Cancer. wcrf.org/sites/default/files/Kidney-Cancer-2015-Report.pdf. Accessed August 31, 2017.
25. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Liver Cancer. wcrf.org/sites/default/files/Liver-Cancer-2015-Report.pdf. Accessed? 2017. Accessed August 31, 2017.
26. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity, and Stomach Cancer. wcrf.org/sites/default/files/Stomach-Cancer-2016-Report.pdf. Accessed August 31, 2017.
27. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Oesophageal Cancer. wcrf.org/sites/default/files/CUP%20OESOPHAGEAL_WEB.pdf. Accessed August 31, 2017.
28. World Cancer Research Fund International/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Colorectal Cancer. wcrf.org/sites/default/files/CUP%20Colorectal%20Report_2017_Digital.pdf. Accessed August 31, 2017.
29. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Breast Cancer. wcrf.org/sites/default/files/CUP_BREAST_REPORT_2017_WEB.pdf. Accessed August 31, 2017.
30. National Program of Cancer Registries (NPCR) and Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: NPCR and SEER Incidence USCS 2005-2014 Public Use Research Database. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; and Bethesda, MD: National Cancer Institute; 2017. Released August 2017, based on the November 2016 submission. cdc.gov/cancer/npcr/public-use. Accessed August 31, 2017.
31. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) and Centers for Disease Control and Prevention, National Center for Health Statistics. SEER*Stat Database: Mortality-All COD, Total US (1990-2014) -Linked To County Attributes-Total US, 1969-2015 Counties. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, released December 2016. Underlying mortality data provided by the National Center for Health Statistics.
32. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002;94:1537-1545.
33. North American Association of Central Cancer Registries. Delay Adjustment. Springfield, IL: North American Association of Central Cancer Registries; 2017. naaccr.org/delay-adjustment/. Accessed August 31, 2017.
34. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2014. Bethesda, MD: National Cancer Institute; 2016. seer.cancer.gov/csr/1975_2014/. Based on November 2016 SEER data submission, posted to the SEER web site April 2017.
35. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Surveys, 2013 and 2014. Public-use data file and documentation. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Health Statistics; 2017. cdc.gov/nchs/nhis/data-questionnaires-documentation.htm. Accessed August 31, 2017.
36. Rey G, Boniol M, Jougla E. Estimating the number of alcohol-attributable deaths: methodological issues and illustration with French data for 2006. Addiction. 2010;105:1018-1029.
37. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health and Nutrition Examination Survey: Questionnaires, Datasets, and Related Documentation. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Health Statistics. cdc.gov/nchs/nhanes/nhanes_questionnaires.htm. Accessed August 31, 2017.
38. Kushi LH, Doyle C, McCullough M, et al. American Cancer Society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin. 2012;62:30-67.
39. Arem H, Moore SC, Patel A, et al. Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship. JAMA Intern Med. 2015;175:959-967.
40. Max W, Sung HY, Shi Y. Deaths from secondhand smoke exposure in the United States: economic implications. Am J Public Health. 2012;102:2173-2180.
41. US Department of Health and Human Services. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
42. Tooze JA, Midthune D, Dodd KW, et al. A new statistical method for estimating the usual intake of episodically consumed foods with application to their distribution. J Am Diet Assoc. 2006;106:1575-1587.
43. Tooze JA, Kipnis V, Buckman DW, et al. A mixed-effects model approach for estimating the distribution of usual intake of nutrients: the NCI method. Stat Med. 2010;29:2857-2868.
44. Greenland S. Interval estimation by simulation as an alternative to and extension of confidence intervals. Int J Epidemiol. 2004;33:1389-1397.
45. Benichou J A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10:195-216.
46. Armstrong BK, Kricker A. How much melanoma is caused by sun exposure? Melanoma Res. 1993;3:395-401.
47. Gloster HM Jr, Neal K. Skin cancer in skin of color. J Am Acad Dermatol. 2006;55:741-760; quiz 761-744.
48. Levy DT, Meza R, Zhang Y, Holford TR. Gauging the effect of US tobacco control policies from 1965 through 2014 using SimSmoke. Am J Prev Med. 2016;50:535-542.
49. Han BH, Moore AA, Sherman S, Keyes KM, Palamar JJ. Demographic trends of binge alcohol use and alcohol use disorders among older adults in the United States, 2005-2014. Drug Alcohol Depend. 2017;170:198-207.
50. Daniel CR, Cross AJ, Koebnick C, Sinha R. Trends in meat consumption in the USA. Public Health Nutr. 2011;14:575-583.
51. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300.
52. Wu S, Cho E, Li WQ, Weinstock MA, Han J, Qureshi AA. History of severe sunburn and risk of skin cancer among women and men in 2 prospective cohort studies. Am J Epidemiol. 2016;183:824-833.
53. Centers for Disease Control and Prevention (CDC). HIV Surveillance Report, 2015. Vol 27. Atlanta, GA: Centers for Disease Control and Prevention; 2015. cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed July 24, 2017.
54. Welzel TM, Graubard BI, Quraishi S, et al. Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States. Am J Gastroenterol. 2013;108:1314-1321.
55. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med. 2003;348:1625-1638.
56. Song M, Giovannucci E. Preventable incidence and mortality of carcinoma associated with lifestyle factors among white adults in the United States. JAMA Oncol. 2016;2:1154-1161.
57. Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000;11:579-588.
58. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender ethnicity. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. J Clin Epidemiol. 1996;49:1441-1446.
59. Drivsholm T, Eplov LF, Davidsen M, et al. Representativeness in population-based studies: a detailed description of nonresponse in a Danish cohort study. Scand J Public Health. 2006;34:623-631.
60. Sauer AG, Siegel RL, Jemal A, Fedewa SA. Updated review of prevalence of major risk factors and use of screening tests for cancer in the United States. Cancer Epidemiol Biomarkers Prev. 2017;26:1192-1208.
61. Andreotti G, Freedman ND, Silverman DT, et al. Tobacco use and cancer risk in the Agricultural Health Study. Cancer Epidemiol Biomarkers Prev. 2017;26:769-778.
62. Carter BD, Abnet CC, Feskanich D, et al. Smoking and mortality—beyond established causes. N Engl J Med. 2015;372:631-640.
63. Jacobs EJ, Newton CC, Carter BD, et al. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking? Ann Epidemiol. 2015;25:179-182 e171.
64. Mader EM, Lapin B, Cameron BJ, Carr TA, Morley CP. Update on performance in tobacco control: a longitudinal analysis of the impact of tobacco control policy and the US adult smoking rate, 2011-2013. J Public Health Manag Pract. 2016;22:E29-E5.
65. Frazer K, Callinan JE, McHugh J, et al. Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption [serial online]. Cochrane Database Syst Rev. 2016;2:CD005992.
66. Islami F, Ward EM, Jacobs EJ, et al. Potentially preventable premature lung cancer deaths in the USA if overall population rates were reduced to those of educated whites in lower-risk states. Cancer Causes Control. 2015;26:409-418.
67. Campaign for Tobacco-Free Kids. State Cigarette Excise Tax Rates and Rankings. Washington, DC: Campaign for Tobacco-Free Kids; 2017. tobaccofreekids.org/research/factsheets/pdf/0097.pdf. Accessed August 15, 2017.
68. American Nonsmokers' Rights Foundation. Overview List—How Many Smokefree Laws? Berkeley, CA: American Nonsmokers' Rights Foundation; 2017. no-smoke.org/pdf/mediaordlist.pdf. Accessed August 16, 2017.
69. American Cancer Society Cancer Action Network. How Do You Measure Up? A Progress Report on State Legislative Activity to Reduce Cancer Incidence and Mortality. 15th ed. Atlanta, GA: American Cancer Society; 2017. acscan.org/sites/default/files/National%20Documents/HDYMU-2017.pdf. Accessed August 15, 2017.
70. Maciosek MV, LaFrance AB, Dehmer SP, et al. Updated priorities among effective clinical preventive services. Ann Fam Med. 2017;15:14-22.
71. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting smoking among adults—United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2017;65:1457-1464.
72. Jemal A, Fedewa SA. Lung cancer screening with low-dose computed tomography in the United States-2010 to 2015. JAMA Oncol. 2017;3:1278-1281.
73. Emmons KM, Colditz GA. Realizing the potential of cancer prevention—the role of implementation science. N Engl J Med. 2017;376:986-990.
74. Brawley OW. The role of government and regulation in cancer prevention. Lancet Oncol. 2017;18:e483-e493.
75. Praud D, Rota M, Rehm J, et al. Cancer incidence and mortality attributable to alcohol consumption. Int J Cancer. 2016;138:1380-1387.
76. Blot WJ, Tarone RE. Doll and Peto's quantitative estimates of cancer risks: holding generally true for 35 years [serial online]. J Natl Cancer Inst. 2015;107:djv044.
77. Colditz GA, Wei EK. Preventability of cancer: the relative contributions of biologic and social and physical environmental determinants of cancer mortality. Annu Rev Public Health. 2012;33:137-156.
78. McCullough ML, Patel AV, Kushi LH, et al. Following cancer prevention guidelines reduces risk of cancer, cardiovascular disease, and all-cause mortality. Cancer Epidemiol Biomarkers Prev. 2011;20:1089-1097.
79. Kabat GC, Matthews CE, Kamensky V, Hollenbeck AR, Rohan TE. Adherence to cancer prevention guidelines and cancer incidence, cancer mortality, and total mortality: a prospective cohort study. Am J Clin Nutr. 2015;101:558-569.
80. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315:2284-2291.
81. Ogden CL, Carroll MD, Lawman HG, et al. Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA. 2016;315:2292-2299.
82. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE, Miech RA. Monitoring the Future. National Survey Results on Drug Use, 1975-2014: Volume 2, College Students and Adults Ages 19-55. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2015.
83. An R, Xiang X, Yang Y, Yan H. Mapping the prevalence of physical inactivity in US States, 1984-2015 [serial online]. PLoS One. 2016;11:e0168175.
84. Wilfley DE, Staiano AE, Altman M, et al. Improving access and systems of care for evidence-based childhood obesity treatment: conference key findings and next steps. Obesity (Silver Spring). 2017;25:16-29.
85. Song M, Hu FB, Wu K, et al. Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies [serial online]. BMJ. 2016;353:i2195.
86. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378:815-825.
87. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13-27.
88. Mead E, Brown T, Rees K, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years [serial online]. Cochrane Database Syst Rev. 2017;6:CD012651.
89. Al-Khudairy L, Loveman E, Colquitt JL, et al. Diet, physical activity and behavioural interventions for the treatment of overweight or obese adolescents aged 12 to 17 years [serial online]. Cochrane Database Syst Rev. 2017;6:CD012691.
90. Cauchi D, Glonti K, Petticrew M, Knai C. Environmental components of childhood obesity prevention interventions: an overview of systematic reviews. Obes Rev. 2016;17:1116-1130.
91. Samdal GB, Eide GE, Barth T, Williams G, Meland E. Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; systematic review and meta-regression analyses [serial online]. Int J Behav Nutr Phys Act. 2017;14:42.
92. US Preventive Services Task Force, Grossman DC, Bibbins-Domingo K, et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force recommendation statement. JAMA. 2017;318:167-174.
93. Simoneau H, Kamgang E, Tremblay J, Bertrand K, Brochu S, Fleury MJ. Efficacy of extensive intervention models for substance use disorders: a systematic review [published online ahead of print 2017]. Drug Alcohol Rev. doi: 10.1111/dar.12590.
94. National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much—A Clinician's Guide, 2005. Rockville, MD: National Institutes of Health; 2005.
95. US Preventive Services Task Force, Grossman DC, Bibbins-Domingo K, et al. Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2017;317:2417-2426.
96. Moyer VA, US Preventive Services Task Force. Screening for and management of obesity in adults: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;157:373-378.
97. Shuval K, Leonard T, Drope J, et al. Physical activity counseling in primary care: insights from public health and behavioral economics. CA Cancer J Clin. 2017;67:233-244.
98. Dunstone K, Brennan E, Slater MD, et al. Alcohol harm reduction advertisements: a content analysis of topic, objective, emotional tone, execution and target audience [serial online]. BMC Public Health. 2017;17:312.
99. Sallis JF, Cerin E, Conway TL, et al. Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study. Lancet. 2016;387:2207-2217.
100. Silver LD, Ng SW, Ryan-Ibarra S, et al. Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: a before-and-after study [serial online]. PLoS Med. 2017;14:e1002283.
101. Andreyeva T, Long MW, Brownell KD. The impact of food prices on consumption: a systematic review of research on the price elasticity of demand for food. Am J Public Health. 2010;100:216-222.
102. Finkelstein EA, Zhen C, Nonnemaker J, Todd JE. Impact of targeted beverage taxes on higher- and lower-income households. Arch Intern Med. 2010;170:2028-2034.
103. National Center for Chronic Disease Prevention and Health Promotion. Excessive Alcohol Use—Preventing a Leading Risk for Death, Disease, and Injury. At a Glance 2016. Atlanta, GA: Centers for Disease Control and Prevention; 2015.
104. Wagenaar AC, Salois MJ, Komro KA. Effects of beverage alcohol price and tax levels on drinking: a meta-analysis of 1003 estimates from 112 studies. Addiction. 2009;104:179-190.
105. Guy GP Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the US, 2002-2006 and 2007-2011. Am J Prev Med. 2015;48:183-187.
106. Jemal A, Ward EM, Johnson CJ, et al. Annual Report to the Nation on the status of cancer, 1975-2014, featuring survival [serial online]. J Natl Cancer Inst. 2017;109:djx030.
107. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol. 2017;177:359-372.
108. US Department of Health and Human Services. The Surgeon General's Call to Action to Prevent Skin Cancer. Washington, DC: US Department of Health and Human Services, Office of the Surgeon General; 2014.
109. ® )-Health Professional Version. Bethesda, MD: National Cancer Institute; 2002. Updated 2017. cancer.gov/types/skin/hp/skin-prevention-pdq. Accessed August 31, 2017.
110. Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29:257-263.
111. Ghiasvand R, Weiderpass E, Green AC, Lund E, Veierod MB. Sunscreen use and subsequent melanoma risk: a population-based cohort study [published online ahead of print Sept 12, 2016]. J Clin Oncol. 2016. doi: 10.1200/JCO.2016.67.5934.
112. Mounessa JS, Caravaglio JV, Dellavalle RP. Comparison of regional and state differences in melanoma rates in the United States: 2003 vs 2013. JAMA Dermatol. 2017;153:345-347.
113. Everett Jones S, Guy GP, Jr. Sun safety practices among schools in the United States. JAMA Dermatol. 2017;153:391-397.
114. Glanz K, Saraiya M, Wechsler H; Centers for Disease Control and Prevention. Guidelines for school programs to prevent skin cancer. MMWR Recomm Rep. 2002;51:1-18.
115. Lazovich D, Isaksson Vogel R, Weinstock MA, Nelson HH, Ahmed RL, Berwick M. Association between indoor tanning and melanoma in younger men and women. JAMA Dermatol. 2016;152:268-275.
116. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for skin cancer: US Preventive Services Task Force recommendation statement. JAMA. 2016;316:429-435.
117. Madigan LM, Lim HW. Tanning beds: impact on health, and recent regulations. Clin Dermatol. 2016;34:640-648.
118. Guy GP Jr, Berkowitz Z, Everett Jones S, Watson M, Richardson LC. Prevalence of indoor tanning and association with sunburn among youth in the United States. JAMA Dermatol. 2017;153:387-390.
119. Grad YH, Lipsitch M, Aiello AE. Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities. Am J Epidemiol. 2012;175:54-59.
120. Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011;60:1644-1649.
121. Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-713.
122. Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112:212-239.
123. Islami F, Miller KD, Siegel RL, Fedewa SA, Ward EM, Jemal A. Disparities in liver cancer occurrence in the United States by race/ethnicity and state. CA Cancer J Clin. 2017;67:273-289.
124. Mitchell AE, Colvin HM, Palmer Beasley R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology. 2010;51:729-733.
125. Allison RD, Hale SA, Harvey BJ, et al. The American College of Preventive Medicine position statement on hepatitis C virus infection. Am J Prev Med. 2016;50:419-426.
126. Torres HA, Shigle TL, Hammoudi N, et al. The oncologic burden of hepatitis C virus infection: a clinical perspective. CA Cancer J Clin. 2017;67:411-431.
127. Williams WW, Lu PJ, O'Halloran A, et al. Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR Surveill Summ. 2017;66:1-28.
128. Jemal A, Fedewa SA. Recent hepatitis C virus testing patterns among baby boomers. Am J Prev Med. 2017;53:e31-e33.
129. Robbins HA, Pfeiffer RM, Shiels MS, Li J, Hall HI, Engels EA. Excess cancers among HIV-infected people in the United States [serial online]. J Natl Cancer Inst. 2015;107. pii: dju503.
130. de Martel C, Shiels MS, Franceschi S, et al. Cancers attributable to infections among adults with HIV in the United States. AIDS. 2015;29:2173-2181.
131. Park LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016;30:273-291.
132. US Department of Health and Human Services. HIV and Immunizations. Rockville, MD: AIDSinfo, US Department of Health and Human Services; 2017. aidsinfo.nih.gov/understanding-hiv-aids/fact-sheets/21/57/hiv-and-immunizations/#. Accessed July 28, 2017.
133. Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2017;67:100-121.
134. Simard EP, Ward EM, Siegel R, Jemal A. Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin. 2012;62:118-128.
135. Enomoto LM, Bann DV, Hollenbeak CS, Goldenberg D. Trends in the incidence of oropharyngeal cancers in the United States. Otolaryngol Head Neck Surg. 2016;154:1034-1040.
136. Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A. International trends in anal cancer incidence rates. Int J Epidemiol. 2017;46:924-938.
137. Immunization Expert Work Group, Committee on Adolescent Health Care. Committee Opinion No. 704: Human Papillomavirus Vaccination. Obstet Gynecol. 2017;129:e173-e178.
138. Walker TY, Elam-Evans LD, Singleton JA, et al. National, Regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66:874-882.
139. Richardson DB, Cole SR, Chu H, Langholz B. Lagging exposure information in cumulative exposure-response analyses. Am J Epidemiol. 2011;174:1416-1422.
140. Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58-S68.
141. Wild CP. How much of a contribution do exposures experienced between conception and adolescence make to the burden of cancer in adults? Cancer Epidemiol Biomarkers Prev. 2011;20:580-581.
142. Levi Z, Kark JD, Katz LH, et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: a population-based study. Cancer. 2017;123:4022-4030.